For coronavirus patients, and all patients, being without a bed means being without a place to go.
It’s senior leadership’s job — including board members — to mitigate the effects of this pandemic.
Evaluating healthcare workforce supply and demand.
Five things for payers to keep in mind as they look to tap into the booming primary care market.
Specialty drugs represent an opportunity to better serve patients, but also pose risks.
The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.
A one-size-fits-all SDOH approach isn't the answer. Yet it's the industry norm.
Here's how we did on last year's predictions and what emerging trends to expect next.
In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.
Five workstreams to help leaders adopt a new organizational approach.
